|
AQR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.23890000000871E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.235240E-04 |
| Normal-vs-Stage2 |
3.424200E-03 |
| Normal-vs-Stage3 |
1.93309999996227E-06 |
| Normal-vs-Stage4 |
2.1505999999949E-05 |
| Stage1-vs-Stage2 |
8.908000E-01 |
| Stage1-vs-Stage3 |
1.521990E-01 |
| Stage1-vs-Stage4 |
1.781770E-01 |
| Stage2-vs-Stage3 |
4.070200E-01 |
| Stage2-vs-Stage4 |
4.336200E-01 |
| Stage3-vs-Stage4 |
9.459000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.17540000005501E-06 |
| Normal-vs-AfricanAmerican |
4.945700E-02 |
| Normal-vs-Asian |
9.169300E-04 |
| Caucasian-vs-AfricanAmerican |
3.663200E-01 |
| Caucasian-vs-Asian |
9.478600E-01 |
| AfricanAmerican-vs-Asian |
4.757200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.36889999999379E-05 |
| Normal-vs-Female |
2.08599999999004E-05 |
| Male-vs-Female |
7.114400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.600200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.63809000000015E-05 |
| Normal-vs-Age(61-80Yrs) |
2.31219999999865E-05 |
| Normal-vs-Age(81-100Yrs) |
1.032410E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.784800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.495600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.795000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.960800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.921200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.682800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.755170E-01 |
| Classical-VS-Follicular |
1.012180E-01 |
| Classical-VS-Other |
2.432600E-01 |
| Classical-VS-Normal |
2.623400E-04 |
| Tall-VS-Follicular |
8.255800E-01 |
| Tall-VS-Other |
6.152200E-01 |
| Tall-VS-Normal |
3.649000E-04 |
| Follicular-VS-Other |
5.940200E-01 |
| Follicular-VS-Normal |
9.93289999999813E-05 |
| Other-VS-Normal |
1.297830E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.39269999999792E-05 |
| Normal-vs-N1 |
3.81400000000198E-05 |
| N0-vs-N1 |
5.291000E-01 |
|
|
